Trexquant Investment’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-27,446
| Closed | -$93.6K | – | 1620 |
|
|
2024
Q3 | $93.6K | Sell |
27,446
-445,269
| -94% | -$1.52M | ﹤0.01% | 1480 |
|
|
2024
Q2 | $2.21M | Buy |
472,715
+273,510
| +137% | +$1.28M | 0.03% | 709 |
|
|
2024
Q1 | $1.48M | Sell |
199,205
-42,549
| -18% | -$316K | 0.03% | 765 |
|
|
2023
Q4 | $2.45M | Buy |
241,754
+54,245
| +29% | +$550K | 0.06% | 487 |
|
|
2023
Q3 | $1.46M | Buy |
187,509
+107,776
| +135% | +$841K | 0.04% | 604 |
|
|
2023
Q2 | $656K | Buy |
79,733
+56,244
| +239% | +$463K | 0.02% | 897 |
|
|
2023
Q1 | $170K | Buy |
+23,489
| New | +$170K | ﹤0.01% | 1345 |
|
|
2022
Q4 | – | Sell |
-49,978
| Closed | -$612K | – | 1451 |
|
|
2022
Q3 | $612K | Buy |
+49,978
| New | +$612K | 0.02% | 731 |
|
|
2022
Q1 | – | Sell |
-17,634
| Closed | -$468K | – | 1444 |
|
|
2021
Q4 | $468K | Buy |
+17,634
| New | +$468K | 0.03% | 677 |
|
|
2021
Q2 | – | Sell |
-26,467
| Closed | -$1.11M | – | 1186 |
|
|
2021
Q1 | $1.11M | Buy |
+26,467
| New | +$1.11M | 0.1% | 252 |
|
|
2020
Q4 | – | Sell |
-9,394
| Closed | -$264K | – | 1128 |
|
|
2020
Q3 | $264K | Buy |
9,394
+1,401
| +18% | +$39.4K | 0.02% | 970 |
|
|
2020
Q2 | $236K | Buy |
+7,993
| New | +$236K | 0.02% | 985 |
|
|
2019
Q2 | – | Sell |
-15,242
| Closed | -$373K | – | 885 |
|
|
2019
Q1 | $373K | Sell |
15,242
-81,169
| -84% | -$1.99M | 0.03% | 674 |
|
|
2018
Q4 | $2.19M | Buy |
96,411
+81,311
| +538% | +$1.85M | 0.14% | 218 |
|
|
2018
Q3 | $480K | Buy |
+15,100
| New | +$480K | 0.04% | 550 |
|
|
2018
Q2 | – | Sell |
-48,265
| Closed | -$1.6M | – | 972 |
|
|
2018
Q1 | $1.6M | Buy |
+48,265
| New | +$1.6M | 0.11% | 295 |
|
|
2017
Q4 | – | Sell |
-19,556
| Closed | -$470K | – | 1089 |
|
|
2017
Q3 | $470K | Buy |
+19,556
| New | +$470K | 0.12% | 295 |
|
|
2017
Q2 | – | Sell |
-24,303
| Closed | -$542K | – | 872 |
|
|
2017
Q1 | $542K | Buy |
+24,303
| New | +$542K | 0.07% | 497 |
|